Yohei Doi

60PUBLICATIONS
142CO-AUTHORS
Respiratory diseasesMedical infection agents (incl. prions)Major global burdens of diseaseEnvironmental epidemiologySocial determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Sep 16, 2026
Comorbidities and Patient Outcomes in Carbapenem-Resistant Gram-negative Bacterial Infections.

|Aug 17, 2026
Phenotypic screening of hypervirulent Klebsiella pneumoniae using tellurite resistance and carbohydrate fermentation testing.

|Apr 27, 2026
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan.

|Apr 08, 2026
A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

Akito Kawai, Christi L McElheny, Ryan K Shields

|Apr 06, 2026
Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in Escherichia coli.

Madison E Stellfox, Yohei Doi

|Mar 08, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections.

Natalie A Mackow, Wanying Shao, Lizhao Ge

Pageof 10

Frequent Collaborators

15 joint publications

David van Duin

12 joint publications

Masahiro Suzuki

11 joint publications

Ryan K Shields

7 joint publications

Daria Van Tyne